SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: chirodoc who wrote (56)	6/5/1998 10:31:00 PM
From: Prospector	Read Replies (3) of 5402

ALL :::: While all of ya are gettin ready fer the big game .. I've been slavin away over this dam old type writer.. I'm gonna get me one of those electric ones .. one of these days.. I have to pry up the keys when they stick..with a crow bar.. anyway I've been over this thing a hundred times, so the dr won't be too mad at me.. I hope it is right... spellin... Prospector...... QUOTE """"""""" I am Dr. Thomas Drees Chairman and CEO of Sanguine Corporation a Nevada Public Company on an over the counter Bulletin Board, symbol SGNC. Sanguine has developed a synthetic red blood cell for oxygenation of the human body in transfusions. 2. The medical world needs a Synthetic Blood. One that does not need donors, safety testing, typing and cross matching or refrigeration. That describes Sanguines Corporation PHER 02. 3. We need a transfusion material that has a longer shelf life than the six weeks for donor blood. Sanguines FER 02 has a 3 year shelf life 27 times longer than donors blood six weeks. 4. Medicine needs a transfusion solution that has a Zero risk of Aids, Hepatitis B, C and CJD a new disease in human blood. That is Sanguine PHER 02. 5. The world needs a transfusion substitute for blood which also can also be used for heart attacks , cancer, strokes and a hundred other medical indications including transplant organ perfusions, burns, shock, eye surgery and others. 6. Sanquines PHER 02 synthetic blood substitute has an unlimited raw material supply unlike human blood which depends on scarce donors. 7. Sanguines PHER 02 can be manufactured at a much lower cost than can human blood that must be collected from rare donors that require multiple testing centrifuging and refrigeration. 8. Sanguines PHER 02 synthetic artificial red blood cells carry 4 times as much oxygen as an equal volume of human blood in a transfusion. 9. Sanguines PHER 02 synthetic blood particle is 1/900 the size of a human red blood cell and thus can get into capillaries much easier than human red cells. 10. Sanguine Corporation is having its synthetic blood research and development completed at Battelle Memorial Institute in Columbus Ohio. Battelle is the worlds largest research lab and animal trials will be started there SOON.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next